Softwr

Healthcare · head to head

Ibex Medical Analytics vs Rx30

Ibex Medical Analytics logo

Ibex Medical Analytics

Healthcare

Cancer detection AI for breast, prostate and gastric pathology deployed in routine clinical service, not just pilots

From
On request
Rated
-
Full reviewWebsite
Rx30 logo

Rx30

Healthcare

Long-established pharmacy management system for independents and small chains

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Ibex Medical Analytics the European IVDR indication is broader than the United States position, where some applications operate under laboratory developed test arrangements rather than FDA authorisation, which determines whether AI output can influence a signed report.; Rx30 shares ownership with PioneerRx, so the two are not the independent alternatives a shortlist implies, and roadmap priorities are set centrally
  • They diverge on capability: Ibex Medical Analytics covers Ibex Breast Suite, Rx30 covers Prescription processing.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Ibex Medical Analytics and Rx30 actually diverge.

Attributes where Ibex Medical Analytics and Rx30 differ
AttributeIbex Medical AnalyticsRx30
PlatformsWeb, Cloud, On-premiseWindows, Web

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Ibex Medical Analytics

  • Ibex Breast Suite
  • Ibex Prostate
  • Ibex Gastric
  • Second read safety net
  • Prescreening triage
  • Heatmap localisation
  • Quality reporting
  • Scanner-agnostic ingestion

Only in Rx30

  • Prescription processing
  • Claims adjudication
  • Inventory and purchasing
  • Point of sale
  • Delivery management
  • Clinical documentation

What people use each for

The jobs each tool is most often brought in to do.

Ibex Medical Analytics

  • A histopathology department that cannot recruit and wants an automated safety net on every prostate and breast biopsy before sign outnot Rx30
  • A private laboratory group standardising Gleason grading across pathologists with known interobserver variabilitynot Rx30
  • A service digitising histopathology that needs a clinical governance argument to justify the scanning programme to its boardnot Rx30
  • A gastrointestinal service wanting Helicobacter pylori detection automated so pathologists spend their time on the neoplastic casesnot Rx30

Rx30

  • Independent pharmacies and small chains wanting a mature, widely-supported systemnot Ibex Medical Analytics
  • Operations relying on a broad set of wholesaler and PBM interfacesnot Ibex Medical Analytics
  • Pharmacies with significant front-end retail alongside dispensingnot Ibex Medical Analytics
  • Multi-store independents needing consistency across locationsnot Ibex Medical Analytics

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Ibex Medical Analytics

  • The European IVDR indication is broader than the United States position, where some applications operate under laboratory developed test arrangements rather than FDA authorisation, which determines whether AI output can influence a signed report.
  • It requires a fully digitised histopathology workflow, and slide scanning, storage and validation typically cost several times the algorithm licence.
  • Running it as a second read safety net adds a discrepancy resolution workload that departments consistently underestimate, and someone senior has to adjudicate every flag.
  • Coverage is limited to breast, prostate and gastric, so a general histopathology department still reads the majority of its case mix without any AI support.
  • Pricing is per case and unpublished, so cost scales directly with biopsy volume and does not flatten as the department grows.

Rx30

  • Shares ownership with PioneerRx, so the two are not the independent alternatives a shortlist implies, and roadmap priorities are set centrally
  • The interface shows its age against newer entrants, and this is the most common objection in demonstrations
  • Pricing is not published, and total cost including hardware and interfaces needs to be requested explicitly
  • Windows-centric, with a cloud story less developed than newer competitors
  • US-only, tied to US insurance and regulatory requirements

Pricing, plan by plan

Ibex Medical Analytics

On request
  • Ibex clinical applications$undefined/year
    • Priced per case analysed under an annual agreement
    • Breast, prostate and gastric licensed as separate suites
    • Regulatory indication differs between Europe and the United States

Rx30

On request
  • Rx30$undefined/month
    • Prescription processing
    • Claims adjudication
    • Inventory

Which should you pick?

Choose Ibex Medical Analytics if

  • You need ibex breast suite.
  • You work on Web, Cloud, On-premise.
  • You also want ibex prostate.
Ibex Medical Analytics review

Choose Rx30 if

  • You need prescription processing.
  • You work on Windows, Web.
  • You also want claims adjudication.
Rx30 review

Questions people ask

Is Ibex Medical Analytics or Rx30 better?
Neither clearly leads. Ibex Medical Analytics starts at On request and Rx30 at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Ibex Medical Analytics or Rx30?
Ibex Medical Analytics starts at On request and Rx30 at On request.
Does Ibex Medical Analytics or Rx30 run on more platforms?
Ibex Medical Analytics runs on Web, Cloud, On-premise. Rx30 runs on Windows, Web.
What is Ibex Medical Analytics best used for?
Ibex Medical Analytics is most often used for a histopathology department that cannot recruit and wants an automated safety net on every prostate and breast biopsy before sign out, a private laboratory group standardising gleason grading across pathologists with known interobserver variability, a service digitising histopathology that needs a clinical governance argument to justify the scanning programme to its board, a gastrointestinal service wanting helicobacter pylori detection automated so pathologists spend their time on the neoplastic cases. Of those, a histopathology department that cannot recruit and wants an automated safety net on every prostate and breast biopsy before sign out and a private laboratory group standardising gleason grading across pathologists with known interobserver variability are not what Rx30 is typically brought in for.
What can Ibex Medical Analytics do that Rx30 cannot?
Ibex Medical Analytics covers Ibex Breast Suite, Ibex Prostate, Ibex Gastric, Second read safety net. Rx30 covers Prescription processing, Claims adjudication, Inventory and purchasing, Point of sale.

Answered from the vendors’ own pages

Ibex Medical Analytics: Is Ibex FDA cleared?

The regulatory position differs by product and market. In Europe the products carry CE marking under IVDR for defined diagnostic indications; in the United States some applications are used under laboratory developed test arrangements. Confirm the exact status for the specific application and market before assuming it can influence a signed report.

Rx30: Is Rx30 the same company as PioneerRx?

Both are owned by RedSail Technologies. They are sold as separate products to overlapping markets, but roadmap decisions sit with one company, which is worth knowing before treating them as independent options.

Ibex Medical Analytics: Second read or prescreening?

Both are supported. Second read as a safety net is the more common clinical governance justification; prescreening is the efficiency case.

Rx30: What does it cost?

Not published. Request the total including hardware, interfaces and training rather than the monthly software fee.

Ibex Medical Analytics: Does it need a particular scanner?

It ingests from the major whole slide scanner vendors rather than requiring a single fleet, which is a practical advantage over vendors tied to one scanner.

Rx30: Why do pharmacies stay on it?

Installed base maturity. The interfaces to wholesalers, PBMs and hardware are long established, and those are the things that quietly stop a pharmacy working when they break.

Ibex Medical Analytics: What tissue types are covered?

Breast, prostate and gastric. Everything else in the case mix is unsupported.

Rx30: How does it compare to PioneerRx?

PioneerRx is more aggressively developed around clinical services. Rx30 has the larger legacy base and broader front-end retail heritage. Same owner, different emphasis.

Rx30: Is it suitable for a small chain?

Yes, and that is one of its stronger cases. Multi-store consistency is better handled here than by the systems aimed purely at single independents.

Share

Related pages

More on Ibex Medical Analytics

More on Rx30

Keep looking

Other head to heads